Analysis of their expression levels in tumor patients and normal subjects identified five core prognostic markers, which were EIF4EBP1, BCL2A1, NDRG1, ERRFI1 and BRD4 (Figure 5B). The gene discussed is BRD4; the disease is neoplasm.